Altis Labs is an early stage company that develops imaging biomarkers using deep learning to accelerate clinical development of promising cancer therapies.
In order to build, test and validate their deep learning algorithms on datasets from public sources (such as TCIA) as well as from their customers, Altis Labs is using the QIPCM platform to ingest imaging datasets, collect labels, train algorithms on GPU enabled VMs and run testing and validation on the HPC4Health compute cluster.
Only anonymized images are sent to QIPCM, after which they are archived in our safe, secure, and backed-up PACS. Access to these images are logged and made available only to permitted personnel. Permitted personnel can thus log-in to the QIPCM platform to review trial images anytime, from anywhere with internet access.
WEBSITE | LINKEDIN